本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Psyence Biomedical Ltd

0.4381
-0.0267-5.74%
盤後0.43810.00000.00%18:55 EDT
成交量:15.65萬
成交額:6.90萬
市值:193.95萬
市盈率:-0.01
高:0.4770
開:0.4665
低:0.4137
收:0.4648
資料載入中...
2025/03/13

SEC問詢函

Form CORRESP - Correspondence
2025/01/28

SEC問詢函

Form CORRESP - Correspondence
2025/01/24

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/12/30

SEC問詢函

Form CORRESP - Correspondence
2024/12/20

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/12/13

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/12/09

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/12/04

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/07

SEC問詢函

Form CORRESP - Correspondence
2024/10/30

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/10/08

SEC問詢函

Form CORRESP - Correspondence
2024/10/02

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/08/27

SEC問詢函

Form CORRESP - Correspondence
2024/08/20

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/07/31

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/07/27

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/05/13

SEC問詢函

Form CORRESP - Correspondence